WAY · Waystar Holding Corp.
Market Cap
$4.96B
Shares
191.75M
WAY metrics
82 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$25.76
Market cap
$4.96B
Price action
19 metricsPrice change (1W)
+6.4%
Price change (30D)
+13.7%
Price change (3M)
+23.7%
Price change (6M)
-3.1%
Price change (YTD)
-21.3%
Price change (1Y)
-32.0%
Trailing year
Price change (5Y)
—
52-week high
$40.89
52-week low
$17.31
Change from 52-week high
-37.0%
Change from 52-week low
+48.8%
Annualized volatility
52.9%
Beta
0.6
RSI (14D)
60.1
Price vs SMA 50
+11.6%
Price vs SMA 200
+1.4%
Avg volume (3M)
2.73M
Relative volume
0.8
Average dollar volume
$60.58M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
191.75M
Valuation
12 metricsP / E (TTM)
36.8
Trailing earnings · reciprocal yield 2.7%
PEG ratio
2.2
EV / revenue
5.3×
reciprocal yield 18.8%
EV / EBITDA
14.9×
reciprocal yield 6.7%
EV / EBIT
23.3×
reciprocal yield 4.3%
P / sales
4.1×
reciprocal yield 24.2%
P / book
1.2
reciprocal yield 80.1%
FCF yield
4.9%
TTM · current market cap
Buyback yield
—
P / FCF
20.2
reciprocal yield 4.9%
P / operating cash flow
17.0
reciprocal yield 5.9%
Earnings yield
2.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.5×
reciprocal yield 15.3%
EV / revenue historical average (5Y)
6.5×
reciprocal yield 15.3%
EV / EBIT historical average (3Y)
31.5×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
31.5×
reciprocal yield 3.2%
EV / EBITDA historical average (3Y)
18.3×
reciprocal yield 5.5%
EV / EBITDA historical average (5Y)
18.3×
reciprocal yield 5.5%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-29
Profitability
9 metricsGross margin
—
Operating margin
22.9%
Trailing 12 months
Net margin
11.2%
Gross profit (TTM)
—
Operating profit (TTM)
$275.76M
Net income (TTM)
$134.79M
Trailing 12 months
Diluted EPS (TTM)
$0.70
FCF margin
20.4%
Effective tax rate
30.9%
Growth
11 metricsRevenue growth YoY
+18.1%
Year over year
Net income growth YoY
+27.0%
Revenue (TTM)
$1.21B
Trailing 12 months
EPS growth YoY
+16.7%
Shares change YoY
+7.1%
Year over year · more shares
Revenue CAGR (3Y)
+16.0%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+49.2%
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
3.4%
Return on assets
2.3%
Debt / equity
0.4
Current ratio
1.8
EBITDA (TTM)
$432.42M
Free cash flow (TTM)
$246.26M
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
3.4
Return on invested capital
3.5%
Trailing 12 months
Net cash
−$1.45B
Latest balance sheet
Cash & equivalents
$12.64M
Total assets
$5.87B
Total debt
$1.47B
Cash flow & spend
7 metricsOperating cash flow (TTM)
$292.99M
Capital expenditures (TTM)
$46.73M
R&D (TTM)
$67.01M
SG&A (TTM)
—
Stock compensation (TTM)
$49.04M
R&D / revenue
5.6%
Stock compensation / revenue
4.1%
Ownership (13F)
3 metrics13F filers
304
13F filer change QoQ
-4
Institutional ownership
111.0%
Short interest
3 metricsShort interest
7.1%
Latest settlement · 4.5 days to cover
Days to cover
4.5d
Short-squeeze score
63 / 100
Insider activity
2 metricsNet insider buying (90D)
−$3.68M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1990354
CUSIP
946784105
13F (30d)
232 filings
231 filers
Visit website
Investor relations